A novel direct adenosine monophosphate kinase activator ameliorates disease progression in preclinical models of Autosomal Dominant Polycystic Kidney Disease
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A novel direct adenosine monophosphate kinase activator ameliorates disease progression in preclinical models of Autosomal Dominant Polycystic Kidney Disease
Authors
Keywords
-
Journal
KIDNEY INTERNATIONAL
Volume 103, Issue 5, Pages 917-929
Publisher
Elsevier BV
Online
2023-02-20
DOI
10.1016/j.kint.2023.01.026
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Metformin Therapy in Autosomal Dominant Polycystic Kidney Disease: A Feasibility Study
- (2021) Godela M. Brosnahan et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- The chloride channel CFTR is not required for cyst growth in an ADPKD mouse model
- (2021) Khaoula Talbi et al. FASEB JOURNAL
- Primary results of the randomized trial of metformin administration in polycystic kidney disease (TAME PKD)
- (2021) Ronald D. Perrone et al. KIDNEY INTERNATIONAL
- Efficacy and safety of PXL770, a direct AMP kinase activator, for the treatment of non-alcoholic fatty liver disease (STAMP-NAFLD): a randomised, double-blind, placebo-controlled, phase 2a study
- (2021) Kenneth Cusi et al. Lancet Gastroenterology & Hepatology
- Metformin induces lactate accumulation and accelerates renal cyst progression in Pkd1-deficient mice
- (2021) Ming-Yang Chang et al. HUMAN MOLECULAR GENETICS
- Tolvaptan vs. somatostatin in the treatment of ADPKD: A review of the literature
- (2021) Ivana Capuano et al. CLINICAL NEPHROLOGY
- AMPK and TOR: The Yin and Yang of Cellular Nutrient Sensing and Growth Control
- (2020) Asier González et al. Cell Metabolism
- Metabolic Reprogramming in Autosomal Dominant Polycystic Kidney Disease
- (2020) Kristen L. Nowak et al. Clinical Journal of the American Society of Nephrology
- Renal cyst growth is attenuated by a combination treatment of tolvaptan and pioglitazone, while pioglitazone treatment alone is not effective
- (2020) Anish A. Kanhai et al. Scientific Reports
- Targeting AMP-activated protein kinase (AMPK) for treatment of autosomal dominant polycystic kidney disease
- (2020) Xuewen Song et al. CELLULAR SIGNALLING
- Acute Kidney Injury among Salicylate Intoxication Hospitalizations in the United States
- (2020) Charat Thongprayoon et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- AMP-activated protein kinase: the current landscape for drug development
- (2019) Gregory R. Steinberg et al. NATURE REVIEWS DRUG DISCOVERY
- Salsalate, but not metformin or canagliflozin, slows kidney cyst growth in an adult-onset mouse model of polycystic kidney disease
- (2019) Wouter N. Leonhard et al. EBioMedicine
- HIF-1α promotes cyst progression in a mouse model of autosomal dominant polycystic kidney disease
- (2018) Andre Kraus et al. KIDNEY INTERNATIONAL
- The combination of metformin and 2-deoxyglucose significantly inhibits cyst formation in miniature pigs with polycystic kidney disease
- (2018) Xiaoying Lian et al. BRITISH JOURNAL OF PHARMACOLOGY
- Polycystic kidney disease
- (2018) Carsten Bergmann et al. Nature Reviews Disease Primers
- Selective Activation of AMPK β 1-Containing Isoforms Improves Kidney Function in a Rat Model of Diabetic Nephropathy
- (2017) Christopher T. Salatto et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Mitochondrial Abnormality Facilitates Cyst Formation in Autosomal Dominant Polycystic Kidney Disease
- (2017) Yu Ishimoto et al. MOLECULAR AND CELLULAR BIOLOGY
- AMPK: guardian of metabolism and mitochondrial homeostasis
- (2017) Sébastien Herzig et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- New treatment paradigms for ADPKD: moving towards precision medicine
- (2017) Matthew B. Lanktree et al. Nature Reviews Nephrology
- High-Throughput Phenotypic Screening of Kinase Inhibitors to Identify Drug Targets for Polycystic Kidney Disease
- (2017) Tijmen H. Booij et al. SLAS Discovery
- Salsalate (Salicylate) Uncouples Mitochondria, Improves Glucose Homeostasis, and Reduces Liver Lipids Independent of AMPK-β1
- (2016) Brennan K. Smith et al. DIABETES
- Growth Differentiation Factor 15 as a Novel Biomarker for Metformin
- (2016) Hertzel C. Gerstein et al. DIABETES CARE
- Variable Cyst Development in Autosomal Dominant Polycystic Kidney Disease: The Biologic Context
- (2016) W. N. Leonhard et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- AMPK antagonizes hepatic glucagon-stimulated cyclic AMP signalling via phosphorylation-induced activation of cyclic nucleotide phosphodiesterase 4B
- (2016) M. Johanns et al. Nature Communications
- 2-Deoxy-D-Glucose Ameliorates PKD Progression
- (2015) M. Chiaravalli et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Risk of Lactic Acidosis or Elevated Lactate Concentrations in Metformin Users With Renal Impairment: A Population-Based Cohort Study
- (2014) Willemijn L. Eppenga et al. DIABETES CARE
- Imaging Classification of Autosomal Dominant Polycystic Kidney Disease: A Simple Model for Selecting Patients for Clinical Trials
- (2014) M. V. Irazabal et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase
- (2014) Anila K. Madiraju et al. NATURE
- Kidney: polycystic kidney disease
- (2014) Binu M. Paul et al. Wiley Interdisciplinary Reviews-Developmental Biology
- AMPK dysregulation promotes diabetes-related reduction of superoxide and mitochondrial function
- (2013) Laura L. Dugan et al. JOURNAL OF CLINICAL INVESTIGATION
- Macrophages promote polycystic kidney disease progression
- (2013) Katherine I Swenson-Fields et al. KIDNEY INTERNATIONAL
- Defective glucose metabolism in polycystic kidney disease identifies a new therapeutic strategy
- (2013) Isaline Rowe et al. NATURE MEDICINE
- AMPK Is a Negative Regulator of the Warburg Effect and Suppresses Tumor Growth In Vivo
- (2012) Brandon Faubert et al. Cell Metabolism
- Formation of cysts by principal-like MDCK cells depends on the synergy of cAMP- and ATP-mediated fluid secretion
- (2011) Bjoern Buchholz et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Metformin: The Safest Hypoglycaemic Agent in Chronic Kidney Disease?
- (2011) Helen J. Nye et al. NEPHRON CLINICAL PRACTICE
- Activating AMP-activated protein kinase (AMPK) slows renal cystogenesis
- (2011) V. Takiar et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Elevated TGFβ-Smad signalling in experimental Pkd1 models and human patients with polycystic kidney disease
- (2010) Sabrine Hassane et al. JOURNAL OF PATHOLOGY
- Polycystic Kidney Disease
- (2008) Peter C. Harris et al. Annual Review of Medicine
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now